US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kailera Therapeutics

17.17

-0.2900-1.66%

Post-market: 17.170.00000.00%19:30 EDT

Volume:436.83K

Turnover:7.57M

Market Cap:2.22B

PE:-7.62

High:17.96

Open:17.52

Low:17.00

Close:17.46

52wk High:28.23

52wk Low:16.39

Shares:129.54M

Float Shares:44.92M

Volume Ratio:0.45

T/O Rate:0.97%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.2543

EPS(LYR):-7,819.9811

ROE:-36.90%

ROA:-22.73%

PB:1.99

PE(LYR):0.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Kailera Therapeutics

Exchange:

NASDAQ

Establishment Date:

2024

Employees:

- -

Office Location:

180 Third Avenue,4th Floor,Waltham,Massachusetts,United States

Website:

http://www.kailera.com

Zip Code:

02451

Phone:

Fax:

- -

Introduction:

Kailera Therapeutics, Inc. was incorporated under the laws of Delaware on May 8, 2024. The company is a clinical-stage biotechnology company dedicated to ushering in a new era of obesity treatment through the advancement of a diversified R&D pipeline. It is currently rapidly advancing four clinical-stage product candidates that leverage multiple glucagon-like peptide-1 (GLP-1)-based mechanisms of action and routes of administration.

Directors

Name

Position

John F. Milligan

Chairman and Director

Ronald C. Renaud, Jr.

Chief Executive Officer,Director and President

Adam Koppel

Independent Director

Andrew Kaplan

Independent Director

Christopher Hite

Independent Director

Frank Clyburn, Jr.

Independent Director

Martin Mackay

Independent Director

Michael Gladstone

Independent Director

Yuting Liu

Independent Director

Shareholders

Name

Position

Ronald C. Renaud, Jr.

Chief Executive Officer,Director and President

Paul Burgess

Chief Business Officer and Chief Operating Officer

Douglas Pagán

Chief Financial Officer

Jamie Coleman

Chief Commercial Officer

Paula Cloghessy

Chief People Officer

Scott Akamine

Chief Legal Officer and Secretary

Scott Wasserman

Chief Medical Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/KLRA/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KLRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRA\",,,,,undefined,":{"symbol":"KLRA","market":"US","secType":"STK","nameCN":"Kailera Therapeutics","latestPrice":17.17,"timestamp":1787342400000,"preClose":17.46,"halted":0,"volume":436830,"hourTrading":{"tag":"盘后","latestPrice":17.17,"preClose":17.17,"latestTime":"19:30 EDT","volume":2129,"amount":36551.25,"timestamp":1787355007970,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.016609392898052643,"floatShares":44921899,"shares":129537300,"eps":-2.254252,"marketStatus":"Market Closed","change":-0.29,"latestTime":"08-21 16:00:00 EDT","open":17.52,"high":17.96,"low":17,"amount":7570552.207800001,"amplitude":0.054983,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.254252,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":17.46,"preHourTrading":{"tag":"盘前","latestPrice":17.8,"preClose":17.46,"latestTime":"08:04 EDT","volume":12,"amount":213.55998,"timestamp":1787313854187,"change":0.34,"changeRate":0.019473,"amplitude":0.028637},"postHourTrading":{"tag":"盘后","latestPrice":17.17,"preClose":17.17,"latestTime":"19:30 EDT","volume":2129,"amount":36551.25,"timestamp":1787355007970,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4456496744289272},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRA\",,,,,undefined,":{"symbol":"KLRA","floatShares":44921899,"roa":"-22.73%","roe":"-36.90%","lyrEps":-7819.9811,"volumeRatio":0.4456496744289272,"shares":129537300,"dividePrice":0,"high":17.96,"amplitude":0.054983,"preClose":17.46,"low":17,"week52Low":16.39,"pbRate":"1.99","week52High":28.2271,"institutionHeld":0,"latestPrice":17.17,"eps":-2.254252,"divideRate":0,"volume":436830,"delay":0,"ttmEps":-2.254252,"open":17.52,"prevYearClose":16,"prevWeekClose":17.94,"prevMonthClose":16.94,"prevQuarterClose":22.03,"fiveDayClose":17.94,"twentyDayClose":17.69,"sixtyDayClose":21.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KLRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"KLRA","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-1.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KLRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KLRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1783483200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KLRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KLRA","date":"2026-08-21","current":-7.616717,"percent":1,"low":-21.871461,"twenty":-19.603438,"median":-16.640572,"eighty":-11.334065,"high":-7.746755,"avg":-15.438559,"sd":4.169763,"marketCap":2263578582},"quantilePoints":[{"date":"2026-04-17","current":-12.669466,"twenty":-12.511098,"median":-12.273546,"eighty":-12.035993,"marketCap":1887180368},{"date":"2026-04-24","current":-20.824025,"twenty":-20.917019,"median":-20.433783,"eighty":-14.17085,"marketCap":3101842710},{"date":"2026-05-01","current":-21.741015,"twenty":-21.413894,"median":-20.305085,"eighty":-18.829635,"marketCap":3238432850},{"date":"2026-05-08","current":-19.540824,"twenty":-21.576784,"median":-20.824025,"eighty":-19.524523,"marketCap":2910703445},{"date":"2026-05-15","current":-18.697273,"twenty":-21.521865,"median":-20.058623,"eighty":-18.676401,"marketCap":2785052251},{"date":"2026-05-22","current":-18.332024,"twenty":-21.403595,"median":-19.540824,"eighty":-18.304195,"marketCap":2730646579},{"date":"2026-05-29","current":-19.949555,"twenty":-21.097481,"median":-19.520448,"eighty":-18.332024,"marketCap":2971585983},{"date":"2026-06-05","current":-18.253756,"twenty":-20.940268,"median":-19.530636,"eighty":-18.332024,"marketCap":2718988220},{"date":"2026-06-12","current":-16.992777,"twenty":-20.824025,"median":-19.392985,"eighty":-17.13192,"marketCap":2531159115},{"date":"2026-06-18","current":-16.636224,"twenty":-20.511831,"median":-18.758148,"eighty":-17.050173,"marketCap":2478048816},{"date":"2026-06-26","current":-12.75669,"twenty":-20.227867,"median":-18.684228,"eighty":-17.050173,"marketCap":2676825461},{"date":"2026-07-02","current":-12.855483,"twenty":-20.165517,"median":-18.622605,"eighty":-16.764931,"marketCap":2697555958},{"date":"2026-07-10","current":-12.9728,"twenty":-20.033041,"median":-18.410291,"eighty":-15.433812,"marketCap":2722173424},{"date":"2026-07-17","current":-11.311837,"twenty":-19.949555,"median":-18.314631,"eighty":-13.521103,"marketCap":2373641938},{"date":"2026-07-24","current":-10.743775,"twenty":-19.944337,"median":-17.453687,"eighty":-12.859187,"marketCap":2254441579},{"date":"2026-07-31","current":-10.527665,"twenty":-19.923466,"median":-17.13192,"eighty":-12.704356,"marketCap":2209093616},{"date":"2026-08-07","current":-11.651439,"twenty":-19.849563,"median":-17.071044,"eighty":-11.79378,"marketCap":2444903022},{"date":"2026-08-14","current":-7.973035,"twenty":-19.724778,"median":-16.992777,"eighty":-11.573639,"marketCap":2329696857},{"date":"2026-08-21","current":-7.746755,"twenty":-19.603438,"median":-16.640572,"eighty":-11.334065,"marketCap":2263578582}],"updateTime":1787506987051},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1899116257,"yearFounded":2024,"address":"180 Third Avenue,4th Floor,Waltham,Massachusetts,United States","zipCode":"02451","officePhone":"781 317 0290","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.kailera.com","stockEarnings":[{"period":"1week","weight":-0.0429},{"period":"1month","weight":-0.0349},{"period":"3month","weight":-0.1889},{"period":"6month","weight":0.0731},{"period":"ytd","weight":0.0731}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kailera Therapeutics, Inc. was incorporated under the laws of Delaware on May 8, 2024. The company is a clinical-stage biotechnology company dedicated to ushering in a new era of obesity treatment through the advancement of a diversified R&D pipeline. It is currently rapidly advancing four clinical-stage product candidates that leverage multiple glucagon-like peptide-1 (GLP-1)-based mechanisms of action and routes of administration.","exchange":"NASDAQ","name":"Kailera Therapeutics","nameEN":"Kailera Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KLRA\",market:\"US\",,,undefined,":{"directors":[{"name":"John F. Milligan","position":"Chairman and Director"},{"name":"Ronald C. Renaud, Jr.","position":"Chief Executive Officer,Director and President"},{"name":"Adam Koppel","position":"Independent Director"},{"name":"Andrew Kaplan","position":"Independent Director"},{"name":"Christopher Hite","position":"Independent Director"},{"name":"Frank Clyburn, Jr.","position":"Independent Director"},{"name":"Martin Mackay","position":"Independent Director"},{"name":"Michael Gladstone","position":"Independent Director"},{"name":"Yuting Liu","position":"Independent Director"}],"executives":[{"name":"Ronald C. Renaud, Jr.","position":"Chief Executive Officer,Director and President"},{"name":"Paul Burgess","position":"Chief Business Officer and Chief Operating Officer"},{"name":"Douglas Pagán","position":"Chief Financial Officer"},{"name":"Jamie Coleman","position":"Chief Commercial Officer"},{"name":"Paula Cloghessy","position":"Chief People Officer"},{"name":"Scott Akamine","position":"Chief Legal Officer and Secretary"},{"name":"Scott Wasserman","position":"Chief Medical Officer"}]}}}